<i>In Vitro</i> and <i>In Vivo</i> Efficacy of NITD-916 against Mycobacterium fortuitum
Françoise Roquet‐Banères, Matthéo Alcaraz, Claire Hamela, Jan Abendroth, Thomas E. Edwards, Laurent Kremer
Abstract
Mycobacterium fortuitum represents one of the most clinically relevant rapid-growing mycobacterial species. Treatments are complex due to antibiotic resistance and to severe side effects of effective drugs, prolonged time of treatment, and co-infection with other pathogens.
Topics & Concepts
Mycobacterium fortuitumIn vivoIn vitroMicrobiologyMycobacteriumBiologyBacteriaBiotechnologyGeneticsMycobacterium research and diagnosisTuberculosis Research and EpidemiologyInfectious Diseases and Mycology